Abliva - Living with Mitochondrial Disease - World Mitochondrial Disease Week 2022

(4:55)

Abliva - Designing Therapies for Mitochondrial Disease - World Mitochondrial Disease Week

(2:16)

Abliva leads the way with potential mitochondrial disease treatment

(12:12)

Abliva - Living with Mitochondrial Disease: full interview - World Mitochondrial Disease Week 2022

(9:35)

Abliva - Light Up for Mito during World Mitochondrial Disease Week 2024

(1:14)

Abliva - Introducing Mitochondrial “Mito” Disease - World Mitochondrial Disease Week 2022

(2:32)

Abliva - World Mitochondrial Disease Week 2023

(28)

Abliva - A Patient-Centric Approach to Drug Development - World Mitochondrial Disease Week 2022

(3:47)

Abliva - Introducing Mitochondrial “Mito” Disease

(2:36)

Abliva - Developing the PROMIS Fatigue Mitochondrial Disease Short Form

(2:42)

Abliva - About Lead Candidate KL1333

(2:16)

Abliva - Living with Mito Disease

(2:51)

Abliva participates in World Mitochondrial Disease Week 2023

(1:8)

Abliva - Drug Development in Mito Disease - World Mitochondrial Disease Week 2022

(3:52)

Abliva - Introducing the FALCON study - World Mitochondrial Disease Week

(2:31)

Abliva - Drug Development - Mito Disease

(3:41)

Abliva - Designing Therapies for Mito Disease

(3:39)

Abliva - Abliva’s upcoming Phase 2/3 study with KL1333 - World Mitochondrial Disease Week 2022

(3:43)

Abliva – What is mitochondrial disease?

(1:36)